Open AccessThe position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in special populations
Author(s) -
Adam Wichniak,
Marcin Siwek,
Joanna Rymaszewska,
Małgorzata Janas–Kozik,
Tomasz Wolañczyk,
Przemysław Bieńkowski,
Dominika Dudek,
Janusz Heitzman,
Agata Szulc,
Jerzy Samochowiec
Publication year - 2021
Publication title -
psychiatria polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.414
H-Index - 22
eISSN - 2391-5854
pISSN - 0033-2674
DOI - 10.12740/pp/140287
Subject(s) - partial agonist , aripiprazole , medicine , psychiatry , akathisia , dopamine receptor d2 , tolerability , extrapyramidal symptoms , adverse effect , antipsychotic , dopamine , psychology , pharmacology , schizophrenia (object oriented programming) , agonist , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom